A novel role of cyclinD1 and p16 in clinical pathology and prognosis of childhood medulloblastoma

Medical Oncology

Volumn 27, Issue 3, 2010, Pages 985-991

  Zhao, Xin ^a   Song, Tao ^b   He, Zhoukang ^a   Tang, Lian ^a   Zhu, Yimin ^a  

^a HUNAN CHILDREN'S HOSPITAL   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

CyclinD1; Immunohistochemistry; Medulloblastoma; p16; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P16; RETINOBLASTOMA PROTEIN;

ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CEREBELLUM; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; DOWN REGULATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; METASTASIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; TUMOR DIFFERENTIATION; TUMOR NECROSIS; UPREGULATION;

CELL DIFFERENTIATION; CEREBELLAR NEOPLASMS; CEREBELLUM; CHILD; CHILD, PRESCHOOL; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; FEMALE; FOURTH VENTRICLE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-1; GENES, P16; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; NECROSIS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77956929659     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12032-009-9320-y     Document Type: Article

References (25)

1. EY Cho JJ Han YL Choi, et al. 2008 Comparison of Her-2, EGFR and cyclin D1 in primary breast cancer and paired metastatic lymph nodes: an immunohistochemical and chromogenic in situ hybridization study J Korean Med Sci 23 1053 1061 10.3346/jkms.2008.23.6.1053 19119452
2. M Cretnik G Poje V Musani, et al. 2009 Involvement of p16 and PTCH in pathogenesis of melanoma and basal cell carcinoma Int J Oncol 34 1045 1050 1:CAS:528:DC%2BD1MXkt1eju78%3D 19287961
3. Y Dong L Sui K Sugimoto, et al. 2001 Cyclin D1-CDK4 complex, a possible critical factor for cell proliferation and prognosis in laryngeal squamous cell carcinomas Int J Cancer 95 209 215 10.1002/1097-0215(20010720)95:4<209::AID- IJC1036>3.0.CO;2-R 1:STN:280:DC%2BD3MzjtFyqtw%3D%3D 11400112 (Pubitemid 32592086)
4. JG Douglas JL Barker RG Ellenbogen, et al. 2004 Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure Int J Radiat Oncol Biol Phys 58 1161 1164 15001259
5. CG Eberhart JL Kepner PT Goldthwaite, et al. 2002 Histopathologic grading of medulloblastomas: a Paediatric Oncology Group study Cancer 94 552 560 10.1002/cncr.10189 11900240 (Pubitemid 34081387)
6. SA Eshkoor P Ismail SA Rahman, et al. 2008 p16 gene expression in basal cell carcinoma Arch Med Res 39 668 673 10.1016/j.arcmed.2008.06.003 1:CAS:528:DC%2BD1cXhtVKlsrfJ 18760195
7. D Haidopoulos GA Partsinevelos GD Vlachos, et al. 2009 p16 INK4A is a strong biomarker for cervical intraepithelial neoplasia and invasive cervical carcinoma: a reappraisal Reprod Sci 16 685 693 10.1177/1933719109334259 1:CAS:528:DC%2BD1MXosVOrtLs%3D 19372590
8. A Iwasa Y Oda S Kurihara, et al. 2008 Malignant transformation of mature cystic teratoma to squamous cell carcinoma involves altered expression of p53- and p16/Rb-dependent cell cycle regulator proteins Pathol Int 58 757 764 10.1111/j.1440-1827.2008.02307.x 1:CAS:528:DC%2BD1MXotFOktg%3D%3D 19067849
9. A Kamb NA Gruis JF Weaver, et al. 1994 A cell cycle regulator potentially involved in genesis of many tumor types Science 264 436 440 10.1126/science.8153634 1:CAS:528:DyaK2cXktVKhtb0%3D 8153634
10. J Koh GH Enders BD Dynlacht, et al. 1995 Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition Nature 375 506 510 10.1038/375506a0 1:CAS:528:DyaK2MXmtFCgsb0%3D 7777061
11. L Krakowczyk JK Strzelczyk B Adamek, et al. 2008 Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa Med Sci Monit 14 BR219 BR225 1:CAS:528:DC%2BD1cXhsVSiur%2FN 18830187
12. T Krecicki R Smigiel M Fraczek, et al. 2004 Studies of the cell cycle regulatory proteins P16, cyclin D1 and retinoblastoma protein in laryngeal carcinoma tissue J Laryngol Otol 118 676 680 10.1258/0022215042244769 15509364
13. JM Lamont CS McManamy AD Pearson SC Clifford DW Ellison 2004 Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients Clin Cancer Res 10 5482 5493 10.1158/1078-0432.CCR-03-0721 1:CAS:528:DC%2BD2cXmvFSltb4%3D 15328187 (Pubitemid 39100486)
14. J Lukas L Aagaard M Strauss, et al. 1995 Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 Control Cancer Res 55 4818 4823 1:CAS:528:DyaK2MXptFKiur0%3D
15. Kong Lingfei Ying Pingzhang Liu Zhengguo, et al. 1998 A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers Cancer Lett 130 93 101 10.1016/S0304-3835(98)00115-3 1:STN:280:DyaK1cvitFyrsw%3D%3D 9751261 (Pubitemid 28425342)
16. RH Medema RE Herrera F Lam, et al. 1995 Growth suppression by p16ink4 requires functional retinoblastoma protein Proc Natl Acad Sci USA 92 6289 6293 10.1073/pnas.92.14.6289 1:CAS:528:DyaK2MXmslKqt7g%3D 7603984
17. N Paul 1994 Ordering S phase and M phase in the cell cycle Cell 79 547 550 10.1016/0092-8674(94)90539-8 (Pubitemid 24363797)
18. RJ Packer BR Rood TJ MacDonald 2003 Medulloblastoma: present concepts of stratification into risk groups Pediatr Neurosurg 39 60 67 10.1159/000071316 12845195 (Pubitemid 36829097)
19. J Pizem A Cort L Zadravec-Zaletel M Popovic 2005 Survivin is a negative prognostic marker in medulloblastoma Neuropathol Appl Neurobiol 31 422 428 10.1111/j.1365-2990.2005.00664.x 1:CAS:528:DC%2BD2MXpslWisr0%3D 16008826 (Pubitemid 41059863)
20. MD Ris R Packer J Goldwein, et al. 2001 Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study J Clin Oncol 19 3470 3476 1:STN:280: DC%2BD3MvjtlOmsw%3D%3D 11481352
21. CJ Sherr JM Roberts 1999 CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev 13 1501 1512 10.1101/gad.13.12.1501 1:CAS:528:DyaK1MXktlOhsLs%3D 10385618
22. RE Taylor CC Bailey K Robinson, et al. 2003 Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study J Clin Oncol 21 1581 1591 10.1200/JCO.2003.05.116 1:CAS:528:DC%2BD2cXptlCksLk%3D 12697884 (Pubitemid 46594113)
23. SL Wolden IJ Dunkel MM Souweidane, et al. 2003 Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma J Clin Oncol 21 3079 3083 10.1200/JCO.2003.11.140 12915597 (Pubitemid 46606288)
24. PM Zeltzer JM Boyett JL Finlay, et al. 1999 Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study J Clin Oncol 17 832 845 1:CAS:528:DyaK1MXhvFGgur0%3D 10071274
25. FU Zhi-jie MA Zhi-yong WANG Qi-rong, et al. 2008 Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinomain Chinese patients Clin Exp Metastasis 25 887 892 10.1007/s10585-008-9207-x